Boss Translational Medicine Ltd entered the industry of Commercial Medical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Julian Ambrus by calling (716) 882-2051 during business hours. You can also write to the business’ Single Location at 541 West Ferry St, Buffalo, New York NY 14222. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Boss Translational Medicine Ltd |
| Representative: | Julian Ambrus |
| Place of Business: | 541 West Ferry St, Buffalo, NY 14222 |
| Contact Number: | (716) 882-2051 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2013 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Boss Translational Medicine Ltd is a company operating from Erie, New York providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Boss Translational Medicine Ltd has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Julian Ambrus at (716) 882-2051 for related queries, or to locate its Single Location using the coordinates 42.91536,-78.880769.
The Single Location can also be found at the street address 541 West Ferry St in Buffalo, New York 14222 and can be engaged online through the company website at , the company Twitter , and Facebook page .